The partnership focuses on providing hospitals across the country with VitalStream wearable hemodynamic monitoring platform.

MicroVention, Inc., a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced its official rebranding to Terumo Neuro, effective immediately.

Terumo Blood and Cell Technologies ... helping developers build more effective workflows as they bring their therapies to market, said Matthew McRae, sales product line manager at Nova. ...

MicroVention, Inc., a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced its official rebranding to Terumo Neuro, effective immediately ...

Terumo Health Outcomes (THO), a division of Terumo Interventional Systems (TIS), today announced a new U.S. distribution agreement with Caretaker Medical to offer Caretaker Medical's VitalStream ...

He continued, "What will evolve is a deeper partnership with Terumo, a new visual brand, and a more defined brand identity under our new name and slogan, ‘Terumo Neuro: Game-changing Impact.’ ...

Terumo BCT’s protocols, tested with Fujifilm’s commercially available, chemically defined, GMP-compliant media, help reduce challenges associated with T cell expansion such as time, cost, and ...

A jury in Jefferson County on Friday morning determined that Lakewood-based Terumo Blood and Cell Technology was not negligent in the release of the chemical ethylene oxide (EtO) into the ...

Terumo Corporation (OTCPK:TRUMF) Q3 2025 Earnings Conference Call February 13, 2025 3:00 AM ETCompany ParticipantsJin Hagimoto – Chief Financial... Skip to content.